In today s New York Times, Mark Winston writes a heart-wrenching column about a problem that will sooner or later come back to sting all of us in a big way massive die-offs of bees.
Catch the latest health news: good news on childhood obesity, non-surprising organic crop study, and why the papaya industry is making news again
Perhaps spurred by last week s seismic announcement by Sage Publications that it was retracting 60(!) papers from one of their journals, Science 2.0 founder Hank Campbell wrote a scathing
A study of organic crops has detected fewer pesticide residues and more antioxidants. While this flies in the face of numerous studies finding no significant differences, these findings even if valid should come as no surprise, despite the hype.
Last December, Hawaii County passed a bill that banned biotech companies from the Big Island and prohibited all new genetically modified crops.
With all the troubles the United States has to deal with around the globe, experts from the University of California-San Francisco think now is a good time to remove tobacco products from military installations. Cold turkey too.
Four years ago, a federal law specified that chain restaurants with more than 20 outlets be required to post the calorie contents of their foods (menu labeling, or ML). The rationale for the law was that if consumers could get a realistic idea of the energy content of their foods, it might encourage them to choose foods with fewer calories and thus help reduce the burden of obesity. But the extent to which restaurant patrons actually use ML to decrease calorie consumption hasn t yet been determined.
The latest health news on e-cigarette safety, childhood obesity rates on the decline, and why calorie information on restaurant menus isn't making a landslide of a difference
Last year, the CDC published a study that found that between 2008 and 2011, the prevalence of obesity among preschoolers declined in 19 out of the 43 states studied. Although childhood obesity is still a major concern with 17 percent (one-sixth) of children in the US documented
A new study shows that a type of androgen-blocking drug, an aromatase inhibitor (marketed since 2005 to reduce the risk of breast cancer) is at least as effective against a common hormonal disorder as standard treatment.
